RHY 2.86% 6.8¢ rhythm biosciences limited

Ann: Dr David Atkins appointed Chief Executive Officer of Rhythm, page-9

  1. 35 Posts.
    lightbulb Created with Sketch. 2
    Has anyone looked at his linked in profile? Very hard for me to assess his suitability for the job but worth a look.

    AboutAbout

    Accomplished global healthcare leader with global markets experience in a broad range of life science and healthcare. Expertise includes clinical and molecular diagnostics, anatomic pathology, wound management, minimally invasive and general surgery, orthopaedics, sterilisation, aesthetics and cell and gene therapy. Business leadership Internationally in US, Canada, EU, Emerging Markets (Middle East, Africa, Asia, Latin America). Start-up ventures, scale-ups, turnaround and high-growth enterprise expertise. Broad functional capability in sales and marketing, R&D pipeline, product development, QRC and operations and business development. Successfully led seed, series B and series C financing as well as operational experience in public markets.
    https://www.linkedin.com/in/datkins1/?originalSubdomain=au
 
watchlist Created with Sketch. Add RHY (ASX) to my watchlist
(20min delay)
Last
6.8¢
Change
-0.002(2.86%)
Mkt cap ! $16.90M
Open High Low Value Volume
7.0¢ 7.0¢ 6.8¢ $47.38K 683.0K

Buyers (Bids)

No. Vol. Price($)
4 246917 6.7¢
 

Sellers (Offers)

Price($) Vol. No.
6.8¢ 184 1
View Market Depth
Last trade - 16.10pm 30/05/2024 (20 minute delay) ?
Last
6.8¢
  Change
-0.002 ( 2.86 %)
Open High Low Volume
7.0¢ 7.0¢ 6.8¢ 162664
Last updated 15.49pm 30/05/2024 ?
RHY (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.